Mind + Muscle

technical minds + legal muscle


dig deep

FDA Releases Quality Considerations Guideline for Biosimilars Production

  • 02.23.12
  • Paul A. Calvo
  • Pharmaceutical Compliance Monitor

In this article, Paul Calvo discusses the FDA's release of the first set of guidance documents outlining the methods of evaluation for regulatory approval of biosimilar products. Dr. Calvo also outlines the nine factors that should be addressed when determining biosimilarity. To read the full article, visit the Pharmaceutical Compliance Monitor website.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.